Gene therapy using adenoviral vector encoding 4-1BBIg gene significantly prolonged murine cardiac allograft survival

Transplant Immunology

Volumn 16, Issue 2, 2006, Pages 88-94

  Huang, Bao Jun ^a,b   Yin, Hui ^a   Huang, Ya Fei ^a   Xu, Jun Fa ^a,c   Xiong, Ping ^a   Feng, Wei ^a   Zheng, Fang ^a   Xu, Yong ^a   Fang, Min ^a   Gong, Fei Li ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

4 1BBIg; Adenovirus; Cardiac transplantation; Costimulation blockade

Indexed keywords

ADENOVIRUS VECTOR; CD137 ANTIGEN; CD137 LIGAND; ENHANCED GREEN FLUORESCENT PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CARDIAC GRAFT REJECTION; CELL INFILTRATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE FUSION; GRAFT SURVIVAL; HEART GRAFT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; SURVIVAL TIME; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

4-1BB LIGAND; ADENOVIRIDAE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD137; GENE THERAPY; GENETIC VECTORS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOGLOBULINS; MICE; MICE, INBRED BALB C; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; TUMOR NECROSIS FACTORS;

EID: 33745984244     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.03.010     Document Type: Article

References (27)

1. Sharpe A.H., and Freeman G.J. The B7-CD28 superfamily. Nat Rev Immunol 2 (2002) 116-126
2. Croft M. Co-stimulatory members of the TNFR family: keys to effective T cell immunity?. Nat Rev Immunol 3 (2003) 609-620
3. Sugamura K., Ishii N., and Weinberg A.D. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat Rev Immunol 4 (2004) 420-431
4. Croft M. Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev 14 (2003) 265-273
5. Kwon B., Kim B.S., Cho H.R., Park J.E., and Kwon B.S. Involvement of tumor necrosis factor receptor superfamily (TNFRSF) members in the pathogenesis of inflammatory diseases. Exp Mol Med 35 (2003) 8-16
6. Dawicki W., and Watts T.H. Expression and function of 4-1BB during CD4 versus CD8 T cell response in vivo. Eur J Immunol 34 (2004) 743-751
7. Futagawa T., Akiba H., Kodama T., Takeda K., Hosoda Y., Yagita H., et al. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. Int Immunol 14 (2002) 275-286
8. - T cells by 4-1BB ligand. Eur J Immunol 33 (2003) 446-454
9. Tan J.T., Ha J.W., Cho H.R., Tucker-Burden C., Hendrix R.C., Mittler R.S., et al. Analysis of expression and function of the costimulatory molecule 4-1BB in alloimmune responses. Transplantation 70 1 (2000) 175-183
10. + T cells. Am J Transplant 3 (2003) 543-551
11. DeFina R., Christopher K., He H.Z., Mandelbrot D., Gu Y., Finn P., et al. Analysis of costimulation by 4-1BBL, CD40L and B7 in graft rejection by gene expression profiles. J Mol Med 81 10 (2003) 655-663
12. Cho H.R., Kwon B., Yagita H., La S., Lee E.A., Kim J.H., et al. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival. Transpl Int 17 (2004) 351-361
13. Guillot C., Guillonneau C., Mathieu P., Gerdes C.A., Menoret S., Braudeau C., et al. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection. J Immunol 168 (2002) 1600-1609
14. Yoshida H., Katayose Y., Unno M., Suzuki M., Kodama H., Takemura S., et al. A novel adenovirus expressing human 4-1BB ligand enhances antitumor immunity. Cancer Immunol Immunother 52 (2003) 97-106
15. Corry R.J., Winn H.J., and Russell P.S. Heart transplantation in congenic strains of mice. Transplant Proc 5 (1973) 733-735
16. Kim H.D., Cao Y.P., Kong F.K., Van Kampen K.R., Lewis T.L., Ma Z., et al. Induction of a Th2 immune response by co-administration of recombinant adenovirus vectors encoding amyloid β-protein and GM-CSF. Vaccine 23 (2005) 2977-2986
17. Overbergh L., Valckx D., Waer M., and Mathieu C. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11 (1999) 305-312
18. Gao W., Demirci G., Strom T.B., and Li X.C. Stimulating PD-1-negative signal concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival. Transplantation 76 (2003) 994-999
19. Ke B., Shen X.D., Gao F., Busuttil R.W., Lowenstein P.R., Castro M.G., et al. Gene therapy for liver transplantation using adenoviral vector: CD40-CD154 blockade by gene transfer of CD40Ig protects rat livers from cold ischemia and reperfusion injury. Molec Ther 9 (2004) 38-45
20. Yamashita K., Masunaga T., Yanagida N., Takehara M., Hashimoto T., Kobayashi T., et al. Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies. Transplantation 76 (2003) 1089-1096
21. Mal G., Bucher P., Morel P., Mei J., Bosco D., Andres A., et al. Anti-CD154 mAb treatment but not recipient CD154 deficiency leads to long-term survival of xenogeneic islet grafts. Am J Transplant 5 (2005) 1021-1031
22. Myers L.M., and Vella A.T. Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation. Trends Immunol 26 (2005) 440-446
23. + T cells. Trends Immunol 23 (2002) 378-380
24. Guillot C.P., Mathieu H., Coathalem B., Le Mauff B., Castro M.G., Tesson L., et al. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. J Immunol 164 (2000) 5258-5268
25. Hurtado J.C., Kim S.H., Pollok K.E., Lee Z.H., and Kwon B.S. Potential role of 4-1BB in T cell activation: comparison with the costimulatory molecule CD28. J Immunol 155 (1995) 3360-3367
26. Vinay D.S., and Kwon B.S. Role of 4-1BB in immune responses. Semin Immunol 10 (1998) 481-489
27. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med 186 1 (1997) 47-55